BIEL Stock Overview
An electroceutical company, engages in the development and sale of wearable, neuromodulation devices to mitigate neurological diseases and enhance quality of life worldwide. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
BioElectronics Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.0002 |
| 52 Week High | US$0.0005 |
| 52 Week Low | US$0.0001 |
| Beta | 0 |
| 1 Month Change | 0% |
| 3 Month Change | -33.33% |
| 1 Year Change | -20.00% |
| 3 Year Change | -83.33% |
| 5 Year Change | -77.78% |
| Change since IPO | -99.96% |
Recent News & Updates
Recent updates
Shareholder Returns
| BIEL | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | -20.0% | -0.2% | 0.2% |
| 1Y | -20.0% | 14.4% | 23.1% |
Return vs Industry: BIEL underperformed the US Medical Equipment industry which returned 13.3% over the past year.
Return vs Market: BIEL underperformed the US Market which returned 21% over the past year.
Price Volatility
| BIEL volatility | |
|---|---|
| BIEL Average Weekly Movement | 47.9% |
| Medical Equipment Industry Average Movement | 8.1% |
| Market Average Movement | 5.9% |
| 10% most volatile stocks in US Market | 18.3% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: BIEL's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: BIEL's weekly volatility has decreased from 75% to 48% over the past year, but is still higher than 75% of US stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2000 | n/a | Kelly Whelan | www.bielcorp.com |
BioElectronics Corporation, an electroceutical company, engages in the development and sale of wearable, neuromodulation devices to mitigate neurological diseases and enhance quality of life worldwide. Its products include ActiPatch, a musculoskeletal pain therapy; Allay, a menstrual pain therapy; and Smart Insole, a heel pain therapy. The company also offers RecoveryRx, a medical device that provides pain management therapy for medical professionals; and HealFast, a drug-free therapy for horses, cats, and dogs that reduces swelling and pain, as well as heals muscle and tendon injuries, sores, and incisions.
BioElectronics Corporation Fundamentals Summary
| BIEL fundamental statistics | |
|---|---|
| Market cap | US$4.94m |
| Earnings (TTM) | -US$289.82k |
| Revenue (TTM) | US$1.61m |
0.0x
P/S Ratio0.0x
P/E RatioIs BIEL overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| BIEL income statement (TTM) | |
|---|---|
| Revenue | US$1.61m |
| Cost of Revenue | US$813.93k |
| Gross Profit | US$795.53k |
| Other Expenses | US$1.09m |
| Earnings | -US$289.82k |
Last Reported Earnings
Dec 31, 2021
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did BIEL perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/02/11 06:01 |
| End of Day Share Price | 2025/02/11 00:00 |
| Earnings | 2021/12/31 |
| Annual Earnings | 2021/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
BioElectronics Corporation is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.